New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

被引：90
作者：
Chen, Lucy F. [1 ]
Cohen, Ezra E. W. [1 ]
Grandis, Jennifer R. [2 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
CLINICAL CANCER RESEARCH | 2010年 / 16卷 / 09期
关键词：
SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE INHIBITORS; LUNG-CANCER; PLUS CETUXIMAB; CONSTITUTIVE ACTIVATION; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; PHASE-II; IN-SITU; EGFR;
D O I：
10.1158/1078-0432.CCR-09-2318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma of the head and neck (HNSCC). However, despite high expression of EGFR in these cancers, EGFR inhibitor monotherapy has only had modest activity. Potential mechanisms of resistance to EGFR-targeted therapies involve EGFR and Ras mutations, epithelial-mesenchymal transition, and activation of alternative and downstream pathways. Strategies to optimize EGFR-targeted therapy in head and neck cancer involve not only the selection for patients most likely to benefit but also the use of combination therapies to target the network of pathways involved in tumor growth, invasion, angiogenesis, and metastasis. Clin Cancer Res; 16(9); 2489-95. (C) 2010 AACR.
引用
收藏
页码：2489 / 2495
页数：7
相关论文
共 50 条
[21]   Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance [J].
Absenger, Gudrun .
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (02) :128-135
[22]   Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib [J].
Giles, Keith M. ;
Kalinowski, Felicity C. ;
Candy, Patrick A. ;
Epis, Michael R. ;
Zhang, Priscilla M. ;
Redfern, Andrew D. ;
Stuart, Lisa M. ;
Goodall, Gregory J. ;
Leedman, Peter J. .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) :2541-2558
[23]   Mechanisms of resistance in head and neck cancer [J].
Picon, Hector ;
Guddati, Achuta Kumar .
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (09) :2742-2751
[24]   Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer [J].
Pernas, Francisco G. ;
Allen, Clint T. ;
Winters, Mary E. ;
Yan, Bin ;
Friedman, Jay ;
Dabir, Bhavana ;
Saigal, Kunal ;
Mundinger, Gerhard S. ;
Xu, Xiaojiang ;
Morris, John C. ;
Calvo, Katherine R. ;
Van Waes, Carter ;
Chen, Zhong .
CLINICAL CANCER RESEARCH, 2009, 15 (07) :2361-2372
[25]   Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7 [J].
Kalinowski, Felicity C. ;
Giles, Keith M. ;
Candy, Patrick A. ;
Ali, Alishum ;
Ganda, Clarissa ;
Epis, Michael R. ;
Webster, Rebecca J. ;
Leedman, Peter J. .
PLOS ONE, 2012, 7 (10)
[26]   How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors [J].
Milik, Sandra N. ;
Lasheen, Deena S. ;
Serya, Rabah A. T. ;
Abouzid, Khaled A. M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 142 :131-151
[27]   Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer [J].
Cohen, Ezra E. W. ;
Haraf, Daniel J. ;
Kunnavakkam, Rangesh ;
Stenson, Kerstin M. ;
Blair, Elizabeth A. ;
Brockstein, Bruce ;
Lester, Eric P. ;
Salama, Joseph K. ;
Dekker, Allison ;
Williams, Rosalyn ;
Witt, Mary Ellyn ;
Grushko, Tatyana A. ;
Dignam, James J. ;
Lingen, Mark W. ;
Olopade, Olufunmilayo I. ;
Vokes, Everett E. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3336-3343
[28]   Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck [J].
Machiels, Jean-Pascal ;
Schmitz, Sandra .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) :1011-+
[29]   Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer [J].
Macarulla, T ;
Casado, E ;
Ramos, FJ ;
Valverde, C ;
Tabernero, J .
ONKOLOGIE, 2006, 29 (03) :99-105
[30]   Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients [J].
Bandres, Eva ;
Barricarte, Ruben ;
Cantero, Cristina ;
Honorato, Beatriz ;
MalumbreS, Raquel ;
Zarate, Ruth ;
Alcalde, Juan ;
Garcia-Foncillas, Jesus .
ORAL ONCOLOGY, 2007, 43 (07) :713-719
12345